Pernix Therapeutics Holdings Inc. (PTX) Purchases CEDAX for $6.1 Million
Many investors in the pharmaceuticals marketplace look for companies that are about to release a new drug product. What they sometimes miss, however, is the earnings potential of drugs that have long since been forgotten about. Many companies have not missed this point, however, and are quietly going about marketing them as valuable inexpensive alternatives. Consolidating companies do not get mentioned all that often but their margins can lead to nice profits. Pernix Therapeutics Holdings Inc. is an acquirer, marketer and distributor of branded pharmaceuticals. The company currently has an extensive product catalogue oriented toward allergies and the affects of…